Physician profile
Amanda Palmer
NPI 1467018895
$2,844.16
in general payments reported to CMS, 2019-2025
19 companies · $1,000 in 2025
The $1,000 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $633 · 2024: $1,211 · 2025: $1,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,665 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,664.71 |
| Education | $179.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $471.16 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $359.97 | 2023-2025 | Dupixent, Libtayo |
| Incyte Corporation | $289.12 | 2023-2025 | Opzelura |
| Janssen Biotech, INC. | $289.07 | 2024-2025 | Tremfya, Simponi, Stelara |
| Lilly USA, LLC | $243.18 | 2023-2025 | Olumiant, Taltz, Ebglyss |
| Genzyme Corporation | $233.59 | 2023-2025 | |
| Galderma Laboratories, L.P. | $167.08 | 2024-2025 | Nemluvio, Aklief |
| Ucb, INC. | $162.69 | 2025 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $139.75 | 2023-2025 | Ilumya |
| Organogenesis INC. | $127.84 | 2023-2025 | Puraply, Via Matrix, Cygnus Dual |
| Paratek Pharmaceuticals, INC. | $78.97 | 2024-2025 | Nuzyra |
| Dermavant Sciences, INC. | $72.07 | 2023-2024 | Vtama |
| Organon LLC | $45.77 | 2025 | Vtama |
| Arcutis Biotherapeutics, INC. | $40.56 | 2024-2025 | Zoryve |
| Verrica Pharmaceuticals INC. | $38.05 | 2023-2024 | Ycanth |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $24.42 | 2024 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $24.00 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.26 | 2024 | Spevigo |
| Pfizer INC. | $17.61 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.